106 results
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
Document or any conduct by a Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
cases);
the enforcement of the judgment is likely to prejudice the sovereignty or security of the State of Israel;
the judgment was obtained by fraud … );
the enforcement of the judgment is likely to prejudice the sovereignty or security of the State of Israel;
the judgment was obtained by fraud;
the opportunity
20-F/A
2023 FY
EX-12.1
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
to adversely affect the company’s ability to record, process, summarize and report financial information; and
Any fraud, whether or not material
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
regulatory approval. Arrangements with providers, consultants, third-party payors and customers are subject to broadly applicable fraud and abuse … reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether
20-F/A
2023 FY
EX-12.2
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
affect the company’s ability to record, process, summarize and report financial information; and
Any fraud, whether or not material, that involves
F-3
6nm1amwb9fy6q
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
6ag1it4ax1rmlq8
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
6qz758i5fzd z2f0
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-10.1
r4frj
21 Sep 22
Current report (foreign)
8:00am
424B5
dqbsc5sp 3ai
20 Sep 22
Prospectus supplement for primary offering
4:30pm
20-F/A
EX-12.1
wsuep70y 7kw74lli
9 Sep 22
Annual report (foreign) (amended)
4:15pm
20-F/A
EX-12.2
z90ft5j xbvw7h
9 Sep 22
Annual report (foreign) (amended)
4:15pm
424B5
mpgki88 26b
3 Sep 21
Prospectus supplement for primary offering
4:29pm